Our Story
We're building the AI that finally makes CTCAE grading effortless. Accurate adverse event assessments in seconds, not hours.


Our Mission
Adverse event grading shouldn't take longer than the clinical judgment it requires. We built Burna AI to automate CTCAE v6.0 assessments with accuracy your team can trust, so coordinators can stop searching and start reviewing.
A single insight can change everything
Your team already knows how to grade adverse events. The problem is everything that comes before: digging through notes, cross-referencing labs, hunting for the right CTCAE criteria.
Burna AI handles the heavy lifting so your clinicians can focus on the decisions that actually require their expertise.
Our core values
Precision
CTCAE grading leaves no room for error. We build for the accuracy that clinical trials and patient safety demand.
Integrity
Every grade comes with citations and evidence. No black boxes. No guesswork. Just transparent, auditable intelligence.
Impact
We measure success in hours returned to your team and confidence gained in every assessment.
Born from necessity and built for scale
Burna AI was born from watching oncology teams drown in manual CTCAE grading. We saw research coordinators spending hours per patient on work that should take minutes. We saw inconsistency across reviewers and audit trails scattered across spreadsheets and PDFs.
So we built the grading assistant oncology deserves.

The Minds Behind Burna AI
Behind Burna is a team that understands both the science and the grind: engineers who've built AI systems at scale, oncologists who've graded thousands of adverse events, and operators who know what it takes to ship compliant software in healthcare.

Nnenna John
CEO

Dr Marc Saint Jour
Chief Medical Officer

Paschal Ezeugwu
Lead Engineer

Dr. Aman Opneja (Advisor)
Chief Clinical Trials Officer, GI Oncology

Dr. James L. Wells III (Advisor)
Hematology/ Oncology

Ryan Joswick (Advisor)
Ex- SVP at Heartland

Dan Storms (Advisor)
Former CPO, CookUnity

Rilwan Lawal (Advisor)
Founder & CEO, GigEasy

Rebecca Greene (Advisor)
Co-Founder & COO, Regal AI
FAQs
Frequently Asked Questions
Have more questions?Contact our support team with any questions you may have.


Toxicity doesn't wait
for documentation.
Grade adverse events the moment they surface
with AI built for oncology.